302 related articles for article (PubMed ID: 33670217)
61. Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006.
Saito R; Li D; Suzuki H
N Engl J Med; 2007 Jan; 356(3):312-3. PubMed ID: 17229966
[No Abstract] [Full Text] [Related]
62. Anti-influenza virus effects of cocoa.
Kamei M; Nishimura H; Takahashi T; Takahashi N; Inokuchi K; Mato T; Takahashi K
J Sci Food Agric; 2016 Mar; 96(4):1150-8. PubMed ID: 25847473
[TBL] [Abstract][Full Text] [Related]
63. San Wu Huangqin Decoction, a Chinese Herbal Formula, Inhibits Influenza a/PR/8/34 (H1N1) Virus Infection In Vitro and In Vivo.
Ma Q; Yu Q; Xing X; Liu S; Shi C; Luo J
Viruses; 2018 Mar; 10(3):. PubMed ID: 29522425
[TBL] [Abstract][Full Text] [Related]
64. Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses.
Liu R; An L; Liu G; Li X; Tang W; Chen X
Antiviral Res; 2015 Aug; 120():101-11. PubMed ID: 26022197
[TBL] [Abstract][Full Text] [Related]
65. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
Checkmahomed L; Padey B; Pizzorno A; Terrier O; Rosa-Calatrava M; Abed Y; Baz M; Boivin G
Viruses; 2020 Oct; 12(10):. PubMed ID: 33049959
[TBL] [Abstract][Full Text] [Related]
66. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
[TBL] [Abstract][Full Text] [Related]
67. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
[TBL] [Abstract][Full Text] [Related]
68. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
Trebbien R; Christiansen CB; Fischer TK
J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
[TBL] [Abstract][Full Text] [Related]
69. [Design of deoxyribozymes for inhibition of influenza A virus].
Evdokimov AA; Mazurkova NA; Malygin EG; Zarytova VF; Levina AS; Repkova MN; Zagrebelnyĭ SN; Netesova NA
Mol Biol (Mosk); 2013; 47(1):83-93. PubMed ID: 23705497
[TBL] [Abstract][Full Text] [Related]
70. Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing
Wang L; Cui Q; Zhao X; Li P; Wang Y; Rong L; Du R
Viruses; 2019 Jul; 11(7):. PubMed ID: 31330768
[TBL] [Abstract][Full Text] [Related]
71. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan.
Saito R; Suzuki Y; Li D; Zaraket H; Sato I; Masaki H; Kawashima T; Hibi S; Sano Y; Shobugawa Y; Oguma T; Suzuki H
J Infect Dis; 2008 Feb; 197(4):630-2; author reply 632-3. PubMed ID: 18275281
[No Abstract] [Full Text] [Related]
72. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret).
Wang Y; Ding Y; Yang C; Li R; Du Q; Hao Y; Li Z; Jiang H; Zhao J; Chen Q; Yang Z; He Z
Biomed Pharmacother; 2017 Jul; 91():393-401. PubMed ID: 28475918
[TBL] [Abstract][Full Text] [Related]
74. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
75. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
Smee DF; Hurst BL; Day CW
Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
[TBL] [Abstract][Full Text] [Related]
76. High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005-2010.
Cho HG; Choi JH; Kim WH; Hong HK; Yoon MH; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Jan; 158(1):241-5. PubMed ID: 23011311
[TBL] [Abstract][Full Text] [Related]
77. Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014.
Liu SS; Jiao XY; Wang S; Su WZ; Jiang LZ; Zhang X; Ke CW; Xiong P
Sci Rep; 2017 Aug; 7(1):8488. PubMed ID: 28814737
[TBL] [Abstract][Full Text] [Related]
78. Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models.
Numata M; Mitchell JR; Tipper JL; Brand JD; Trombley JE; Nagashima Y; Kandasamy P; Chu HW; Harrod KS; Voelker DR
J Biol Chem; 2020 Feb; 295(6):1704-1715. PubMed ID: 31882535
[TBL] [Abstract][Full Text] [Related]
79. Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus.
Derksen A; Kühn J; Hafezi W; Sendker J; Ehrhardt C; Ludwig S; Hensel A
J Ethnopharmacol; 2016 Jul; 188():144-52. PubMed ID: 27178637
[TBL] [Abstract][Full Text] [Related]
80. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
